Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.69 USD | +12.08% | +0.75% | -60.06% |
24/04 | Motion for Asset Sale Approved for Eiger BioPharmaceuticals, Inc. | CI |
19/04 | Selection of Successful Bidder Filed by Eiger BioPharmaceuticals, Inc. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.06% | 3.98M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- EIGR Stock
- News Eiger BioPharmaceuticals, Inc.
- BTIG Adjusts Eiger BioPharmaceuticals' Price Target to $48 from $57, Maintains Buy Rating